Ligation of TLR2 by Versican: A Link Between Inflammation and Metastasis

Archives of Medical Research

Volumn 40, Issue 4, 2009, Pages 321-323

  Wang, Wei ^a   Xu, Ge Liang ^a   Jia, Wei Dong ^a   Ma, Jin Liang ^a   Li, Jian Sheng ^a   Ge, Yong Sheng ^a   Ren, Wei Hua ^a   Yu, Ji Hai ^a   Liu, Wen Bin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Metastasis; Toll like receptor 2; Versican

Indexed keywords

ALPHA CHEMOKINE; CD14 ANTIGEN; INTERLEUKIN 8; PROTEOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; VERSICAN;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CANCER CELL; CANCER INVASION; CANCER THERAPY; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; INFLAMMATION; METASTASIS; NEUTROPHIL CHEMOTAXIS; STROMA;

CYTOKINES; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASMS; TOLL-LIKE RECEPTOR 2; VERSICANS;

EID: 67650022818     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.04.005     Document Type: Article

References (23)

1. Wight T.N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14 (2002) 617-623
2. Kodama J., Hasengaowa, Kusumoto T., et al. Versican expression in human cervical cancer. Eur J Cancer 43 (2007) 1460-1466
3. Skandalis S.S., Kletsas D., Kyriakopoulou D., Stavropoulos M., and Theocharis D.A. The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim Biophys Acta 1760 (2006) 1217-1225
4. Pukkila M., Kosunen A., Ropponen K., et al. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. J Clin Pathol 60 (2007) 267-272
5. Pukkila M., Kosunen A., Ropponen K., et al. Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res 63 (2003) 4786-4791
6. Yamagata M., and Kimata K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci 107 (1994) 2581-2590
7. Cattaruzza S., Schiappacassi M., Ljungberg-Rose A., et al. Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem 277 (2002) 47626-47635
8. Zheng P.S., Wen J., Ang L.C., et al. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18 (2004) 754-756
9. Yee A.J., Akens M., Yang B.L., et al. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 9 (2007) R47
10. Kim S., Takahashi H., Lin W.W., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457 (2009) 102-106
11. Faure E., Thomas L., Xu H., Medvedev A., Equils O., and Arditi M. Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J Immunol 166 (2001) 2018-2024
12. Dunzendorfer S., Lee H.K., and Tobias P.S. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res 95 (2004) 684-691
13. Satta N., Kruithof E.K., Reber G., and de Moerloose P. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Mol Immunol 46 (2008) 145-157
14. Chen S., Wong M.H., Schulte D.J., Arditi M., and Michelsen K.S. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells. J Endotoxin Res 13 (2007) 281-296
15. Mumm J.B., and Oft M. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation. Oncogene 27 (2008) 5913-5919
16. Bulut Y., Faure E., Thomas L., Equils O., and Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 167 (2001) 987-994
17. Lloyd-Jones K.L., Kelly M.M., and Kubes P. Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide. J Immunol 181 (2008) 1446-1453
18. Uehara A., and Takada H. Functional TLRs and NODs in human gingival fibroblasts. J Dent Res 86 (2007) 249-254
19. Satta N., Dunoyer-Geindre S., Reber G., et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109 (2007) 1507-1514
20. Cho M.L., Ju J.H., Kim H.R., et al. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 108 (2007) 121-128
21. Waugh D.J., and Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 14 (2008) 6735-6741
22. Yuan A., Chen J.J., Yao P.L., and Yang P.C. The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10 (2005) 853-865
23. Condeelis J., and Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 (2006) 263-266